Latest Earnings Analysis
-
CELA (SILA) Q4 2025: Tenant Credit Quality Rises to 40.6% Investment Grade, Sharpening Portfolio Resilience
February 25, 2026 · SILA
-
Sun Communities (SUI) Q4 2025: Leverage Falls to 3.4x, Unlocking Capital Allocation Flexibility
February 25, 2026 · SUI
-
Volaris (VLRS) Q4 2025: Ancillary Revenue Hits 56% of Total, Signaling Ultra-Low-Cost Model Strength
February 25, 2026 · VLRS
-
MGPI Q4 2025: Premium Plus Sales Up 10% as Portfolio Rationalization Accelerates
February 25, 2026 · MGPI
-
PAR Pacific (PARR) Q4 2025: Liquidity Jumps 49% as Renewables JV and Inventory Monetization Reshape Balance Sheet
February 25, 2026 · PARR
-
Acadia Healthcare (ACHC) Q4 2025: $200M Embedded EBITDA Upside Hinges on Bed Ramp and Operational Reset
February 25, 2026 · ACHC
-
Tempest (TEM) Q4 2025: Data Licensing Jumps 69% as AI-Driven Platform Pulls Ahead
February 25, 2026 · TEM
-
Solid Power (SLDP) Q4 2025: Liquidity Rises $9M as Pilot Line and OEM Partnerships Advance Commercialization Path
February 25, 2026 · SLDP
-
Matson (MATX) Q4 2025: $307M Buyback and Southeast Asia Expansion Drive Yield Focus
February 25, 2026 · MATX
-
Trex (TREX) Q4 2025: Railing Grows Double Digits as Channel Expansion Drives 2026 Share Ambitions
February 25, 2026 · TREX
-
Westlake Chemical Partners (WLKP) Q4 2025: Distribution Coverage Dips to 0.8x on Turnaround, Recovery Expected in 2026
February 25, 2026 · WLKP
-
OMA (OMAB) Q4 2025: Passenger Traffic Up 6% as New Tariffs and CapEx Reshape Airport Economics
February 25, 2026 · OMAB
-
IIPR Q4 2025: $275M New Investments Signal Portfolio Diversification Amid Cannabis Turnaround
February 25, 2026 · IIPR
-
Viper Energy (VNOM) Q4 2025: Permian Acreage Expands 2.5x, Fueling Organic Growth and Capital Returns
February 25, 2026 · VNOM
-
JBT Morrell (JBTM) Q4 2025: $30M Order Synergies Accelerate Integration, Poultry Demand Powers Outlook
February 25, 2026 · JBTM
-
HealthStream (HSTM) Q4 2025: Credential Stream and ShiftWizard Drive 21%+ Growth, Platform Stickiness Deepens
February 25, 2026 · HSTM
-
Sotera Health (SHC) Q4 2025: Sterigenics Jumps 10.6% as Margin Expansion Drives 20th Year of Growth
February 25, 2026 · SHC
-
NRG (NRG) Q4 2025: LS Power Adds 11 Months, Driving 36% Cash Flow Jump in 2026 Outlook
February 25, 2026 · NRG
-
FIS (FIS) Q4 2025: Recurring ACV Sales Jump 20% as Data Moat Drives AI-Led Banking Growth
February 25, 2026 · FIS
-
Xometry (XMTR) Q4 2025: Marketplace Revenue Jumps 33% as Enterprise Penetration Deepens
February 25, 2026 · XMTR
-
FIS (FIS) Q4 2025: Banking Revenue Surges 8.3%, Recurring Sales Drive Margin Expansion
February 25, 2026 · FIS
-
Bowhead Specialty (BOW) Q4 2025: Casualty Drives 28% Segment Growth as Digital Initiatives Accelerate
February 25, 2026 · BOW
-
First Watch (FWRG) Q4 2025: 19% Margin Anchors Record 64 Openings, Digital and Menu Levers Drive 2026 Playbook
February 25, 2026 · FWRG
-
Galapagos (GLPG) Q4 2025: €295M Operating Profit Signals Strategic Reset as Cell Therapy Wind-Down Lowers Cost Base
February 25, 2026 · GLPG
-
BEAM (BEAM) Q4 2025: $500M Financing Extends Runway, Accelerates PKU and Sickle Cell Launch
February 25, 2026 · BEAM
-
Novanta (NOVT) Q4 2025: Bookings Surge 25% as Backlog and New Product Revenue Hit Record Highs
February 25, 2026 · NOVT
-
DigitalOcean (DOCN) Q4 2025: AI Customer ARR Surges 150%, Fueling 2026 Growth Acceleration
February 25, 2026 · DOCN
-
Quaker Houghton (KWR) Q4 2025: Asia-Pacific Sales Jump 15% as Share Gains Offset Sluggish Americas
February 25, 2026 · KWR
-
UFP Technologies (UFPT) Q4 2025: Revenue Climbs 19.5% as Contract Extensions and Facility Expansion Reshape Growth Outlook
February 25, 2026 · UFPT
-
Recursion (RXRX) Q4 2025: 35% OpEx Cut Extends Runway, AI Platform Delivers First Clinical Proof
February 25, 2026 · RXRX
-
SAM Q4 2025: SunCruiser Volume Jumps 300%, Offsetting Twisted Tea Headwinds
February 25, 2026 · SAM
-
Tennant Company (TNC) Q4 2025: ERP Disruption Drives $30M Sales Impact, Robotics Ambition Raised to $250M
February 25, 2026 · TNC
-
Woodside Energy (WDS) Q4 2025: Scarborough 94% Complete, LNG Expansion Drives $1.9B Free Cash Flow
February 25, 2026 · WDS
-
LOW Q4 2025: $8B ADG/FBM Additions Dilute Margin, Signal Strategic Distribution Pivot
February 25, 2026 · LOW
-
Audity (ODD) Q4 2025: Acquisition Costs Spike Over 2X, Forcing 30% Sales Pullback Amid Platform Dislocation
February 25, 2026 · ODD
-
Immunocore (IMCR) Q4 2025: ChemTrack Revenue Jumps 29% as Pipeline Readouts Approach
February 25, 2026 · IMCR
-
IOVA Q4 2025: MTAGV Drives 30% Revenue Growth as Pipeline Expansion Accelerates
February 25, 2026 · IOVA
-
InfuSystem (INFU) Q4 2025: Gross Margin Expands 260bps as Wound Care and PCDs Fuel Mix Shift
February 25, 2026 · INFU
-
KNSA Q4 2025: Arclist Penetration Reaches 18% as Market Expansion Accelerates
February 25, 2026 · KNSA
-
CORT Q4 2025: 37% Tablet Volume Gain Reveals Cushing Franchise Demand Surge
February 25, 2026 · CORT
-
ESEA Q4 2025: Contracted Coverage Locks in 87% of 2026 Voyage Days at $30K+ Rates
February 25, 2026 · ESEA
-
Euro Holdings (EHLD) Q4 2025: Tanker Fleet Expansion Follows $46.5M Charter-Adjusted Vessel Valuation
February 25, 2026 · EHLD
-
CWH Q4 2025: Inventory Turnover Reset Drives $35M EBITDA Headwind, Reshapes 2026 Margin Trajectory
February 25, 2026 · CWH
-
Angel Oak Mortgage REIT (AOMR) Q4 2025: Net Interest Income Climbs 11% as HELOC Securitizations Scale
February 25, 2026 · AOMR
-
CLEAR (YOU) Q4 2025: Bookings Surge 25%, Clear One Record Validates Enterprise Identity Flywheel
February 25, 2026 · YOU
-
Vera Mobility (VRRM) Q4 2025: NYC Contract Drives $998M Backlog, Margin Reset Signals 2027 Upside
February 25, 2026 · VRRM
-
Zeta (ZETA) Q4 2025: Super-Scaled Customers Now 90% of Revenue, Accelerating Platform Flywheel
February 25, 2026 · ZETA
-
BridgeBio (BBIO) Q4 2025: Atruby Prescriber Base Jumps to 1,856, Signaling Deepening Franchise Penetration
February 25, 2026 · BBIO
-
Westlake (WLK) Q4 2025: $600M Cost Actions Anchor 2026 Margin Reset Amid Global Overcapacity
February 25, 2026 · WLK
-
Avanos (AVNS) Q4 2025: $30M Tariff Headwind Drives Supply Chain Pivot, Specialty Nutrition Outpaces Market
February 25, 2026 · AVNS